French PE fund Jeito Capital invests in global biopharma growth with Aviceda and XyloCor Therapeutics
French PE fund Jeito Capital invests in global biopharma growth with Aviceda and XyloCor Therapeutics Paris-based Jeito Capital, a PE fund focused on biopharma innovation, has furthered its position as a player in global healthcare investment with two major contributions to clinical-stage biotech companies Aviceda Therapeutics and XyloCor Therapeutics – totalling